Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS MONTH'S ISSUE:
August 2016

Diet and Heart Health: a Paradigm Shift?
Recent meta-analyses have found that reducing cholesterol in the diet does not decrease the risk of death from heart disease.

rTMS for Anorexia Nervosa?
One session of high-frequency repetitive transcranial magnetic stimulation (rTMS) showed a trend of reduced symptoms in patients with anorexia nervosa in a small double-blind parallel-group study.

Anticholinergic Drugs in Patients with Dementia
The coprescription of cholinesterase inhibitors and anticholinergic medications in elderly patients with dementia increases with the number of physicians seen.

In Brief
ß-amyloid May Protect against Microbial Infection; Long-Term Use of Tricyclic Antidepressants May Lower Risk of Gliomas

Raloxifene in Postmenopausal Women with Schizophrenia
The selective estrogen receptor modulator raloxifene (Evista) shows promise as an adjunctive treatment for schizophrenia in postmenopausal women.

A Message from Alan J. Gelenberg, M.D.

When I first started writing BTP in the 1970s, it was to bridge the gap between new knowledge in our field and its application to patient care. Over the decades since, the need for this bridge has become even greater. Neuroscience rockets forward. Psychiatrists and other clinicians have a broader array of treatments for patients with mental disorders than we even dreamed of back then. But we have less time to spend with patients and less time to keep up with developments that affect treatment decisions. Our medications, and those prescribed by colleagues in other specialties, are more varied, complex, and prone to interactions. What were formerly crisp boundaries between major psychopharmacologic categories are now murky.

This makes the modern practice of psychiatry challenging—but also fun and promising. With the expanding armamentarium of treatment options comes enhanced ability to alleviate suffering. The mission of BTP remains constant, even while the field grows. We are still here to bridge the gap, to make science applicable and relevant, and to help you in your day-to-day work relieve distress and improve function in patients' lives.